Document is current

Article History

Received: 10 March 2022

Accepted: 5 March 2023

First Online: 29 March 2023

Competing interests

: S.C. is an employee of, and owns shares and stocks in, F. Hoffmann-La Roche Ltd., Switzerland. T.M. is an employee of, and owns shares in, F. Hoffmann-La Roche Ltd., Switzerland. S.A. is an employee of Novartis Pharma AG, Basel, Switzerland. S.B. is an employee of Biogen Digital Health, Biogen International GmbH, Baar, Switzerland. J.A. is an employee of, and holds shares and stocks in, F. Hoffmann-La Roche Ltd., Switzerland. E.B. is an employee of F. Hoffmann-La Roche Ltd., Switzerland. T.K. is an employee of F. Hoffmann-La Roche Ltd., Switzerland. P.S. is an employee of, and owns shares in, F. Hoffmann-La Roche Ltd., Switzerland. D.E. is an employee of SYSNAV, Vernon, France. L.S. is an employee of the University of Oxford, UK, and holds a patent without financial return on a method to assess upper limb function using a wearable device; he has consulted for Biogen, F. Hoffmann-La Roche Ltd., Novartis, Scholar Rock, Pfizer, BioHaven Therapeutics, Sarepta, Santhera, Biophytis, Affinia and Regenexbio; he chairs the DSMB of Lupin therapeutics and FibroGen; he is also the secretary of the World Muscle Society and the Vice Chair of the scientific board of Spinal Muscular Atrophy (SMA) Europe. C.G. is an employee of, and owns shares in, Eli Lilly and Company Ltd., Basingstoke, UK; and is a member of The European Federation of Pharmaceutical Industries and Associations as an Eli Lilly and Company Ltd. representative. A.K. was an employee of, and owned shares in, Eli Lilly and Company Ltd., Basingstoke, UK, during the conceptual design, drafting and review of the manuscript. A.R. is an employee of Bristol Myers Squibb, UK. T.V. is an employee of the European Medicines Agency, Amsterdam, The Netherlands. C.V. is an employee of the European Medicines Agency, Amsterdam, The Netherlands. F.C. is an employee of the European Medicines Agency, Amsterdam, The Netherlands.